Sørensen M, Nielsen H, Kowalski A. "Method for the Synthesis of 1-(2-(4-(o-Tolyl)piperazin-1-yl)ethyl)isoquinoline" [P]. European Patent, EP 3257197 A1, 2020-11-14.
Kumar R, Chen K W, Stevens L M. "A Process for Preparing High-Purity 1-(2-(4-(o-Tolyl)piperazin-1-yl)ethyl)isoquinoline" [P]. US Patent, US 9344264 B2, 2024-10-21.
参考文献 Literature
Kim S H, Park J Y. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". J. Nat. Prod., 2012, 1402, (11), 8347-8357.
Kumar A, Sharma P, Patel R S. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Food Chem., 2015, 1108, (2), 8259-8282.
Mueller T, Schmidt R K. "Identification and Structural Characterization of a Novel Degradation Product of 1-(2-(4-(o-Tolyl)piperazin-1-yl)ethyl)isoquinoline Using HRMS and NMR". Biomed. Chromatogr., 2023, 996, (2), 1580-1607.
Garcia M, Rodriguez P. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Rapid Commun. Mass Spectrom., 2012, 788, 8517-8540.